Stimcell Energetics (STME) Income from Continuing Operations (2016 - 2024)
Stimcell Energetics (STME) posted quarterly Income from Continuing Operations of 124957.0 for Q2 2024, down 57.41% year-over-year from 293397.07 in Q2 2023, and down 85.0% quarter-over-quarter from 67546.0 in Q1 2024.
Stimcell Energetics (STME) Income from Continuing Operations (2016 - 2024) Analysis & Trends
Stimcell Energetics' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 124957.0 for Q2 2024.
- In Q2 2024, Income from Continuing Operations fell 57.41% year-over-year to 124957.0; the TTM figure through May 2024 stood at 330003.0 (up 33.34% YoY), while the FY2024 annual figure was 2145352.0, up 7.11% from the prior year.
- Income from Continuing Operations for Q2 2024 stood at 124957.0, down from 67546.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 60547.0 in Q4 2023, with the low at 356333.0 in Q1 2020.
- The 5-year median for Income from Continuing Operations is 158623.0 (2022), against an average of 160431.22.
- Peak annual rise in Income from Continuing Operations reached 78.9% in 2020, while the deepest fall reached 319.8% in 2020.
- Stimcell Energetics' Income from Continuing Operations stood at 189336.0 in 2020, then climbed by 7.06% to 175977.0 in 2021, then grew by 18.85% to 142813.0 in 2022, then jumped by 57.6% to 60547.0 in 2023, then plunged by 106.38% to 124957.0 in 2024.
- Business Quant data shows STME's Income from Continuing Operations at 124957.0 in Q2 2024, 67546.0 in Q1 2024, and 60547.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -124,957.00 |
| Feb 29, 2024 | -67,546.00 |
| Nov 30, 2023 | -60,547.00 |
| Aug 31, 2023 | -76,953.00 |
| May 31, 2023 | -79,383.00 |
| Feb 28, 2023 | -118,161.00 |
| Nov 30, 2022 | -142,813.00 |
| Aug 31, 2022 | -154,685.00 |
| May 31, 2022 | -162,561.00 |
| Feb 28, 2022 | -119,489.00 |
| Nov 30, 2021 | -175,977.00 |
| Aug 31, 2021 | -239,352.00 |
| May 31, 2021 | -187,629.00 |
| Feb 28, 2021 | -179,008.00 |
| Nov 30, 2020 | -189,336.00 |
| Aug 31, 2020 | -201,202.00 |
| May 31, 2020 | -251,830.00 |
| Feb 29, 2020 | -356,333.00 |
| Nov 30, 2019 | -303,488.00 |
| Aug 31, 2019 | -245,287.00 |